FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021483908> ?p ?o ?g. }

• W2021483908 endingPage "1366" @default.
• W2021483908 startingPage "1352" @default.
• W2021483908 abstract "Abstract Oxidative stress has been implicated as a mechanism underlying hyperglycaemia‐associated cellular damage and could play a role in the development of diabetes‐related complications. This study aimed to evaluate the significance of changes in oxidant–antioxidant status in 176 child and adolescent diabetic patients at clinical onset, during disease progression and when early microvascular complications appeared. Indicative lipid and protein oxidation markers and antioxidant defence activity were measured in plasma and correlated with clinical data, diabetes duration, long‐term glycometabolic control and serum lipids. Compared with their respective age‐matched controls, diabetic patients had greater oxidative damage to lipids and proteins, demonstrated through the analysis of hydroperoxides, lipoperoxides and oxidation protein products, all of which were significantly raised at onset, decreased during the first 1.5 years of evolution and rose progressively thereafter. Plasma levels of oxidizable lipids were significantly associated with lipid and protein oxidation products. Overall, plasma antioxidant capacity was significantly and consistently lower from clinical onset onwards. These results suggest that insulin therapy in the first year improved metabolic and oxidant homeostasis and consequently hyperglycaemia‐derived biomolecular oxidative damage. Diabetes‐associated hyperlipidaemia is related to lipid and protein oxidation processes, which supports the concept of glucose toxicity and lipotoxicity being interrelated. The greatest increase in lipid and protein oxidative damage biomarkers in young diabetic patients with premature microangiopathy points to oxidative stress as a possible contributing mechanism of microvascular dysfunction. Consequently, tight lipid and glycometabolic control may have therapeutic potential by diminishing oxidative tissue‐damaging effects of hyperglycaemia." @default.
• W2021483908 created "2016-06-24" @default.
• W2021483908 creator A5002870949 @default.
• W2021483908 creator A5010481483 @default.
• W2021483908 creator A5024427561 @default.
• W2021483908 creator A5079479624 @default.
• W2021483908 date "2007-08-14" @default.
• W2021483908 modified "2023-10-16" @default.
• W2021483908 title "Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards" @default.
• W2021483908 cites W1163687489 @default.
• W2021483908 cites W1207588145 @default.
• W2021483908 cites W1529592271 @default.
• W2021483908 cites W1584223459 @default.
• W2021483908 cites W1599282808 @default.
• W2021483908 cites W1968138979 @default.
• W2021483908 cites W1978618107 @default.
• W2021483908 cites W1991469067 @default.
• W2021483908 cites W1998614770 @default.
• W2021483908 cites W2000210204 @default.
• W2021483908 cites W2011683287 @default.
• W2021483908 cites W2013529909 @default.
• W2021483908 cites W2016833774 @default.
• W2021483908 cites W2019779869 @default.
• W2021483908 cites W2020046215 @default.
• W2021483908 cites W2022043651 @default.
• W2021483908 cites W2037617948 @default.
• W2021483908 cites W2039933947 @default.
• W2021483908 cites W2040405167 @default.
• W2021483908 cites W2042641359 @default.
• W2021483908 cites W2044437167 @default.
• W2021483908 cites W2059643569 @default.
• W2021483908 cites W2067841909 @default.
• W2021483908 cites W2076236935 @default.
• W2021483908 cites W2083993371 @default.
• W2021483908 cites W2086561195 @default.
• W2021483908 cites W2098946775 @default.
• W2021483908 cites W2101432960 @default.
• W2021483908 cites W2109168147 @default.
• W2021483908 cites W2118473808 @default.
• W2021483908 cites W2121008706 @default.
• W2021483908 cites W2124098523 @default.
• W2021483908 cites W2132837448 @default.
• W2021483908 cites W2134724878 @default.
• W2021483908 cites W2136423491 @default.
• W2021483908 cites W2166266795 @default.
• W2021483908 cites W2416837370 @default.
• W2021483908 cites W2769264260 @default.
• W2021483908 cites W4232003153 @default.
• W2021483908 doi "https://doi.org/10.1111/j.1582-4934.2007.00068.x" @default.
• W2021483908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4401297" @default.
• W2021483908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18205705" @default.
• W2021483908 hasPublicationYear "2007" @default.
• W2021483908 type Work @default.
• W2021483908 sameAs 2021483908 @default.
• W2021483908 citedByCount "17" @default.
• W2021483908 countsByYear W20214839082012 @default.
• W2021483908 countsByYear W20214839082013 @default.
• W2021483908 countsByYear W20214839082014 @default.
• W2021483908 countsByYear W20214839082017 @default.
• W2021483908 countsByYear W20214839082019 @default.
• W2021483908 countsByYear W20214839082020 @default.
• W2021483908 countsByYear W20214839082021 @default.
• W2021483908 countsByYear W20214839082023 @default.
• W2021483908 crossrefType "journal-article" @default.
• W2021483908 hasAuthorship W2021483908A5002870949 @default.
• W2021483908 hasAuthorship W2021483908A5010481483 @default.
• W2021483908 hasAuthorship W2021483908A5024427561 @default.
• W2021483908 hasAuthorship W2021483908A5079479624 @default.
• W2021483908 hasBestOaLocation W20214839082 @default.
• W2021483908 hasConcept C126322002 @default.
• W2021483908 hasConcept C134018914 @default.
• W2021483908 hasConcept C2776151105 @default.
• W2021483908 hasConcept C2776513394 @default.
• W2021483908 hasConcept C2777391703 @default.
• W2021483908 hasConcept C2778004101 @default.
• W2021483908 hasConcept C2780829032 @default.
• W2021483908 hasConcept C2994476132 @default.
• W2021483908 hasConcept C44353895 @default.
• W2021483908 hasConcept C55493867 @default.
• W2021483908 hasConcept C555293320 @default.
• W2021483908 hasConcept C57600042 @default.
• W2021483908 hasConcept C71924100 @default.
• W2021483908 hasConcept C86803240 @default.
• W2021483908 hasConceptScore W2021483908C126322002 @default.
• W2021483908 hasConceptScore W2021483908C134018914 @default.
• W2021483908 hasConceptScore W2021483908C2776151105 @default.
• W2021483908 hasConceptScore W2021483908C2776513394 @default.
• W2021483908 hasConceptScore W2021483908C2777391703 @default.
• W2021483908 hasConceptScore W2021483908C2778004101 @default.
• W2021483908 hasConceptScore W2021483908C2780829032 @default.
• W2021483908 hasConceptScore W2021483908C2994476132 @default.
• W2021483908 hasConceptScore W2021483908C44353895 @default.
• W2021483908 hasConceptScore W2021483908C55493867 @default.
• W2021483908 hasConceptScore W2021483908C555293320 @default.
• W2021483908 hasConceptScore W2021483908C57600042 @default.
• W2021483908 hasConceptScore W2021483908C71924100 @default.
• W2021483908 hasConceptScore W2021483908C86803240 @default.
• W2021483908 hasIssue "6" @default.

• next